ERBB2 and breast carcinoma: Indeed, GRHL2 mRNA was highly expressed in Her2 low and Her2+ luminal lines and, with more variation, in TNBC basal A breast cancer cell lines while it was not or lowly expressed in TNBC basal B cell lines (p < 0.0001); NT5E showed an opposite pattern (Figure 2A).